By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Medicare’s AI approval pilot drew warnings before it launched
    By
    msadmin
    September 16, 2026
    GE HealthCare’s new AI tools forecast hospital bottlenecks 72 hours out
    By
    msadmin
    September 16, 2026
    Knowtex bets on evaluation science to sell clinical AI to hospitals
    By
    msadmin
    September 16, 2026
    Pediatric heart models now take seconds instead of a workday
    By
    msadmin
    September 16, 2026
    OpenAI Foundation puts $40M behind cancer vaccine data collection
    By
    msadmin
    September 16, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Medicare’s AI approval pilot drew warnings before it launched

Thousands of pages released under a FOIA lawsuit show the WISeR pilot launched over vendor warnings and produced testing gaps.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: September 16, 2026
Share
2 Min Read
SHARE

Medicare’s test of algorithmic coverage decisions went live over its own contractors’ warnings, according to more than a thousand pages of newly released records.

WISeR is the program’s name. It went live in January and is set to continue through 2031. Its scope is narrow but consequential: skin substitutes and epidural pain injections now require advance sign-off, and providers in six states have to comply, Texas and Ohio among them.

The records surfaced through a Freedom of Information Act lawsuit filed by the Electronic Frontier Foundation. One message in the pile comes from a vendor. That contractor told the Centers for Medicare and Medicaid Services the launch deadline left no realistic path to a finished product. Elsewhere the files document testing gaps, backlogs and care that arrived late.

This is the largest attempt yet to automate prior authorization inside traditional fee-for-service Medicare. Backers see algorithmic review as a route to less waste and faster routine approvals. Critics say it hands clinical judgment to software that has never been validated at national scale.

STAT, Medscape and Newsweek describe the same cluster of complaints: denials that arrive without clear reasoning, slow turnaround, and few ways for a clinician to push back on a machine’s decision. Democratic lawmakers have already asked CMS to pause WISeR. The new files give that push harder evidence.

CMS has not said whether it will change course. Hospitals want to know two things: whether denials can be appealed fast enough to keep treatment on schedule, and whether accuracy figures will be published while the multi-year experiment runs.

TAGGED:AI regulationcare delaysCMSElectronic Frontier Foundationhealth policyMedicareprior authorization
SOURCES:STAT NewsNewsweek
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

OpenAI Foundation puts $40M behind cancer vaccine data collection

By
msadmin
September 16, 2026
News & Alerts

GenBio launches stateful AIDO Cell to simulate whole human cells

By
msadmin
August 19, 2026
News & Alerts

ECG-only AI predicts significant coronary blockages before scans

By
msadmin
August 20, 2026
News & Alerts

Cancer trial matchmaker Massive Bio climbs OpenAI partner ranks

By
msadmin
August 9, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal